The effect of early trough level of infliximab on subsequent disease course in patients with Crohn disease: A prospective cohort study

Decreased trough level of infliximab (TLI) is associated with diminished efficacy in patients with Crohn disease (CD). We examined whether TLI at 14 weeks subsequent to the start of infliximab (IFX) treatment would impact long-term clinical course. Serum IFX levels and antibodies to IFX (ATI) at 14...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Natsuki, Miyazu, Takahiro, Sugiyama, Tomohiro, Tamura, Satoshi, Kagami, Takuma, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373619/
https://www.ncbi.nlm.nih.gov/pubmed/32702894
http://dx.doi.org/10.1097/MD.0000000000021226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373619/
https://www.ncbi.nlm.nih.gov/pubmed/32702894
http://dx.doi.org/10.1097/MD.0000000000021226

Ejemplares similares